Erythropoietin in kidney disease and type 2 diabetes.
Thomas
T
Thum
Kamyar
K
Kalantar-Zadeh
Stefan D
SD
Anker
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000068256:Darbepoetin alfa; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006333:Heart Failure / Q000209:etiology; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D000090463:Iron Deficiencies; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000401:mortality
D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D007501:Iron